Donald W. DeGolyer - Nov 10, 2025 Form 4 Insider Report for Emergent BioSolutions Inc. (EBS)

Role
Director
Signature
/s/ Richard S. Lindahl, Attorney-in-fact
Stock symbol
EBS
Transactions as of
Nov 10, 2025
Transactions value $
-$187,623
Form type
4
Date filed
11/12/2025, 04:13 PM
Previous filing
Aug 13, 2025
SEC
View on sec.gov

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
DeGolyer Donald W Director 300 PROFESSIONAL DR, GAITHERSBURG /s/ Richard S. Lindahl, Attorney-in-fact 2025-11-12 0001583098

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction EBS Common Stock Sale -$188K -17.8K -12.93% $10.54 120K Nov 10, 2025 Direct F1, F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Represents the number of shares sold by the Reporting Person. Shares were sold pursuant to a Rule 10b5-1 trading plan, dated August 11, 2025, for the purpose of satisfying tax obligations relating to the vesting of RSUs on October 2, 2025.
F2 For reporting purposes, sales prices within a $1 range have been aggregated and the weighted average sales price has been reported. The price ranges were: $10.33 - $10.79. The Company maintains a record of the transactions and copies will be provided upon request.